» Articles » PMID: 29147325

Quality of Life in Patients with Advanced Cancer Using the Functional Assessment of Cancer Therapy-General Assessment Tool: A Literature Review

Overview
Journal World J Oncol
Specialty Oncology
Date 2017 Nov 18
PMID 29147325
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Quality of life (QOL) has become an increasingly meaningful endpoint in advanced cancer research. Clinicians assess QOL to help them select appropriate treatment options and regimens. The present review aims to compare QOL scores of the Functional Assessment of Cancer Therapy-General Assessment Tool (FACT-G) in relation to clinical and socio-demographic features in patients with advanced cancer. A literature search in MEDLINE and EMBASE was conducted; a total of 33 studies encompassing 39 study arms were identified that reported FACT-G scores. Four statistically significant parameters were identified with respect to FACT-G scores: education, national per capita healthcare expenditures, admittance status and previous radiation therapy. A greater percentage of patients completing higher education programs were correlated to significantly better emotional well-being and global QOL. Cohorts from countries with higher national per capita healthcare expenditures had better physical well-being, social/family well-being and improved relationships with their doctors. Patient samples comprised of purely outpatients had better levels of emotional well-being and global QOL when compared to samples with a mix of outpatients and inpatients. A greater percentage of patients previously receiving radiation therapy were correlated to a better relationship with doctor score. Although limitations of the present review exist, differences in QOL scores based on socio-demographic and clinical factors are observed; certain correlations described in the present work have been described previously in the literature while others have not. Future work aimed at either determining confounding parameters or cause and effect relationships is recommended.

Citing Articles

Quality of life and psychological distress of patients with advanced cancer in the Philippines.

Manalo M, Ng S, Ozdemir S, Malhotra C, Finkelstein E, Ong K Qual Life Res. 2023; 32(8):2271-2279.

PMID: 36952074 DOI: 10.1007/s11136-023-03389-y.


The association between socioeconomic position and the symptoms and concerns of hospital inpatients seen by specialist palliative care: Analysis of routinely collected patient data.

Davies J, Sleeman K, Ramsenthaler C, Prentice W, Maddocks M, Murtagh F Palliat Med. 2022; 37(4):575-585.

PMID: 35949141 PMC: 10074756. DOI: 10.1177/02692163221115331.


miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma.

Zhong L, Xu Z, Jin X, He Y, Zhang J, Jiang T Oncol Lett. 2020; 20(6):339.

PMID: 33123250 PMC: 7583731. DOI: 10.3892/ol.2020.12202.


Impact of weight loss on cancer patients' quality of life at the beginning of the chemotherapy.

Alvaro Sanz E, Abiles J, Garrido Siles M, Perez Ruiz E, Alcaide Garcia J, Dominguez A Support Care Cancer. 2020; 29(2):627-634.

PMID: 32424642 DOI: 10.1007/s00520-020-05496-9.


Socioeconomic position and use of healthcare in the last year of life: A systematic review and meta-analysis.

Davies J, Sleeman K, Leniz J, Wilson R, Higginson I, Verne J PLoS Med. 2019; 16(4):e1002782.

PMID: 31013279 PMC: 6478269. DOI: 10.1371/journal.pmed.1002782.

References
1.
Chow E, Harris K, Fan G, Tsao M, Sze W . Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007; 25(11):1423-36. DOI: 10.1200/JCO.2006.09.5281. View

2.
Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta K . Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1998; 50(6):920-8. DOI: 10.1016/S0090-4295(97)00459-7. View

3.
Yoo H, Suh C, Kim S, Eremenco S, Kim H, Kim S . Korean translation and validation of the functional assessment of cancer therapy-lung (FACT-L) version 4. Qual Life Res. 2006; 15(1):161-6. DOI: 10.1007/s11136-005-8752-x. View

4.
Ringash J, Lockwood G, OSullivan B, Warde P, Bayley A, Cummings B . Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiother Oncol. 2008; 87(2):181-7. DOI: 10.1016/j.radonc.2007.12.028. View

5.
Lapitan M, Buckley B . Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort. J Obstet Gynaecol Res. 2011; 37(8):1061-70. DOI: 10.1111/j.1447-0756.2010.01486.x. View